Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2006 Oct;61(10):835-6.
doi: 10.1136/thx.2006.060772.

IL-10: Another therapeutic target in idiopathic pulmonary fibrosis?

A B Millar
Editorial

IL-10: Another therapeutic target in idiopathic pulmonary fibrosis?

A B Millar. Thorax. 2006 Oct.

Abstract

The need for appropriately designed clinical trials in IPF

PubMed Disclaimer

Conflict of interest statement

Competing interests: none declared.

Comment on

References

    1. Millar A. Anti‐cytokine therapy in fibrosing alveolitis: where are we now? Respir Res 200013–5. - PMC - PubMed
    1. Raghu G, Brown K K, Bradford W Z.et al A placebo‐controlled trial of interferon gamma‐1β in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004350125–133. - PubMed
    1. Azuma A, Nukiwa T, Tsuboi E.et al Double‐blind, placebo‐controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 20051711040–1047. - PubMed
    1. Demedts M, Behr J, Buhl R.et al High‐dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 20053532229–2242. - PubMed
    1. Nakagome K, Dohi M, Okunishi K.et al In vivo IL‐10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF‐β in the lung. Thorax 200661886–894. - PMC - PubMed

MeSH terms